Interestingly, with development of bridging fibrosis at week 52, changes in pathways related to hepatic fibrosis/hepatic stellate cells activation decreased as compared to 24 weeks and were mainly limited to increase in genes for Col4a1, Mmp12, Mmp13 and Vcam1 (Fig. 5). This evidence concerns the gene MMP12 and Hepatic fibrosis.